Companies › VYNE

VYNE THERAPEUTICS INC (VYNE)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001566044 · EDGAR filings · Updated 2026-07-28

VYNE THERAPEUTICS INC (VYNE) has reported institutional ownership of 39.5%, with 44 institutional managers holding positions valued at $7.86M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (5)

• 2026-07-28 — Current report (8-K) filed
• 2026-07-24 — Insider transaction reported (Form 4)
• 2026-07-24 — Insider transaction reported (Form 4)
• 2026-07-24 — Insider transaction reported (Form 4)
• 2026-07-24 — Insider transaction reported (Form 4)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-21 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, VYNE THERAPEUTICS INC has 44 institutional holders and institutional ownership of 39.5%.

Insider activity

Insiders reported 18 transactions (0 buys, 0 sells) across 4 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

SS INNOVATIONS INTERNATIONAL COM NEW (SSII) · VISTAGEN THERAPEUTICS INC (VTGN) · TherapeuticsMD Inc (TXMD) · QUOIN PHARMACEUTICALS LTD (QNRX) · DOGWOOD THERAPEUTICS INC (DWTX) · Veru Inc (VERU)